Chromosome 22ql1 fluorescence in situ hybridisation (FISH) studies were performed on 33 consecutive individuals attending a paediatric cardiology clinic with tetralogy of Fallot. Seven children had 22qll microdeletions but only four had other clinical features associated with the newly recognised chromosome 22 deletion syndrome (CATCH 22). Chromosome 22qll FISH studies should therefore be performed on all patients with tetralogy of Fallot. (Arch Dis Child 1996; 74: 62 63) 
Tetralogy of Fallot is the commonest cyanotic congenital cardiac defect and may occur either as an isolated abnormality or in association with other non-cardiac malformations.' 1 . In children with a chromosome abnormality, its origin was investigated through examination of parental blood samples.
Results
Seven families from the 40 who were approached refused a blood sample. The remaining 18 males and 15 females included two children with trisomy 21 Down's syndrome.
Routine chromosome preparations were normal in 30 patients and one was noted to have a coincidental familial chromosome 13 paracentric inversion.
Seven patients had microdeletions at 22ql 1 detected by FISH. Three of these patients were clinically diagnosed as having velocardiofacial syndrome, one in the course of this study and two while attending the cleft palate clinic. In two of these families one parent was not available and both parents in the third family, neither of whom had clinical features, refused to give blood samples, although they had two daughters with velocardiofacial syndrome and 22q1 1 microdeletion.
The fourth patient with a chromosome 22ql 1 microdeletion, which was not present in either parent, had a previous clinical diagnosis Girl with isolated tetralogy ofFallot associated with a chromosome 22ql 1 microdeletion.
of partial DiGeorge syndrome. The remaining three patients with chromosome 22 microdeletions had isolated tetralogy of Fallot with no other clinical features to suggest this underlying chromosome abnormality. In these three, the chromosome deletions were not familial.
Discussion
In this study we identified three patients (1 1%) who have tetralogy of Fallot as the only clinical feature of an underlying chromosome 22ql 1 microdeletion. Recently, this chromosome abnormality has been associated with diverse abnormalities signified by the acronym CATCH 22 (cardiac defects, abnormal facies, thymic aplasia/hypoplasia, cleft palate, hypoparathyroidism, and microdeletion of 22ql 1) .5 While another study of 22ql 1 deletions in tetralogy of Fallot6 confirmed the presence of deletions in the majority of cases associated with velocardiofacial syndrome and DiGeorge syndrome, no deletions were identified in otherwise non-dysmorphic individuals. In fact, the authors of this study admitted that, in some of their cases, suggestive dysmorphic features were only identified after the chromosome abnormality was detected. In our experience, some patients with chromosome 22ql 1 microdeletion have either no dysmorphic features or very subtle features which are easily overlooked ( figure) .
In an epidemiological study of tetralogy of Fallot, I non-cardiac malformations were found in only 27% of patients, made up of 8% with a clinically recognisable syndrome, 8% with chromosome aneuploidy, and 11% with no underlying diagnosis. Therefore, the important implication of our small study is that FISH analysis should be routinely performed in patients where tetralogy of Fallot occurs as an isolated malformation. Identification of this chromosome deletion highlights the possibility of other associated problems, such as immunological disorders or learning disabilities, also known to be associated with 22q1 1 microdeletion. From the parents' perspective, identifying the chromosome deletion clarifies the sibling recurrence risk and facilitates genetic counselling for the affected child who may ask for advice in the future. 
